Cargando…

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients

To gain further insights into the role of T lymphocytes in immune responses against bladder tumors, we developed a method that monitors the presence of functional antigen-specific T cells in the urine of non-muscle invasive bladder cancer patients. As relatively few immune cells can usually be recov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pieraerts, Claire, Martin, Virginie, Jichlinski, Patrice, Nardelli-Haefliger, Denise, Derre, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429573/ https://www.ncbi.nlm.nih.gov/pubmed/22934261 http://dx.doi.org/10.4161/onci.20526

Ejemplares similares

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells
por: Decrausaz, Loane, et al.
Publicado: (2013)

Immunotherapeutic strategies for bladder cancer
por: Chevalier, Mathieu F, et al.
Publicado: (2014)

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
por: Domingos-Pereira, Sonia, et al.
Publicado: (2022)

Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile
por: Lucca, Ilaria, et al.
Publicado: (2022)

Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer
por: Hojeij, Rim, et al.
Publicado: (2016)

Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
por: Benmerzoug, Sulayman, et al.
Publicado: (2021)

Intravaginal TLR agonists increase local vaccine-specific CD8 T-cells and human papillomavirus-associated genital-tumor regression in mice
por: Domingos-Pereira, Sonia, et al.
Publicado: (2012)

What is the influence of vaccination’s routes on the regression of tumors located at mucosal sites?
por: Nardelli-Haefliger, Denise, et al.
Publicado: (2012)

Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion
por: Alonso, Florian, et al.
Publicado: (2016)

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
por: Nguyen, Sylvain, et al.
Publicado: (2022)

Double Positive CD4(+)CD8(+) T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization
por: Bohner, Perrine, et al.
Publicado: (2019)

Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model
por: Domingos-Pereira, Sonia, et al.
Publicado: (2021)

Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
por: Ahn, Jae-Hak, et al.
Publicado: (2022)

Rapid Detection of Recurrent Non-Muscle Invasive Bladder Cancer in Urine Using ATR-FTIR Technology
por: El-Falouji, Abdullah I., et al.
Publicado: (2022)

Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients
por: Chauhan, Pradeep S., et al.
Publicado: (2023)

Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman
por: Valerio, Massimo, et al.
Publicado: (2011)

Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
por: Descotes, Françoise, et al.
Publicado: (2017)

Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
por: Domingos-Pereira, Sonia, et al.
Publicado: (2019)

00005 Urine tumor DNA detects minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy
por: Chen, Kevin, et al.
Publicado: (2021)

SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results
por: Parraud, Delphine, et al.
Publicado: (2023)

SITC 26(th) annual meeting – summary
por: Romano, Emanuela, et al.
Publicado: (2012)

Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma
por: Cussenot, Olivier, et al.
Publicado: (2013)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Multiple Chromatographic Analysis of Urine in the Detection of Bladder Cancer
por: Džubinská, Daniela, et al.
Publicado: (2021)

Detecting and monitoring bladder cancer with exfoliated cells in urine
por: Li, Nannan, et al.
Publicado: (2022)

Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma
por: Yazarlou, Fatemeh, et al.
Publicado: (2018)

Usefulness of Urine Cytology as a Routine Work-up in the Detection of Recurrence in Patients With Prior Non-Muscle-Invasive Bladder Cancer: Practicality and Cost-Effectiveness
por: Ok, Bong Gi, et al.
Publicado: (2014)

Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer
por: Zhang, Xin, et al.
Publicado: (2015)

Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy
por: Morizawa, Yosuke, et al.
Publicado: (2018)

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study
por: Chauhan, Pradeep S., et al.
Publicado: (2021)

Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection
por: Wang, Zhi-Yong, et al.
Publicado: (2018)

Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine
por: Makino, Tomoyuki, et al.
Publicado: (2014)

Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
por: Sieverink, Caroline A., et al.
Publicado: (2020)

Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer?
por: Al-Zubi, Mohammad Talal, et al.
Publicado: (2023)

Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
por: Karashima, Takashi, et al.
Publicado: (2022)

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
por: Batista, Rui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4pk82ie23r9p0dn1ogdb89nsa1